Patent details

Basic Information

Publication number:

EP1073417

PCT Application Number:

PCT/EP/99/02535

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999169212

PCT Publication Number:

WO/99/05390

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL AEROSOL FORMULATION

French Title of Invention:

FORMULATION POUR AEROSOL PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE AEROSOLFORMULIERUNG

SPC Number:

Dates

Filing date:

15/04/1999

Grant date:

04/12/2002

EP Publication Date:

04/12/2002

PCT Publication Date:

28/10/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/02/2001

EP B1 Publication Date:

04/12/2002

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/04/2006

Expiration date:

15/04/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/04/1999

 

 

Name:

GLAXO GROUP LIMITED

Address:

Glaxo Wellcome House Berkeley Avenue, Greenford, Middlesex UB6 ONN, United Kingdom (GB)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

26/02/2003

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CAVAILLON P., Lab. Glaxo Wellcome, Zone Ind. no2

Address:

France (FR)

2

Name:

ROSIER P., Lab. Glaxo Wellcome, Zone Ind. no. 2

Address:

France (FR)

3

Name:

LOUIS O., Lab. Glaxo Wellcome, Zone Ind. No 2

Address:

France (FR)

4

Name:

LLORCA N., Lab. Glaxo Wellcome, Zone Ind. no2

Address:

France (FR)

Priority

1

Priority Number:

9808152

Priority Date:

18/04/1998

Priority Country:

United Kingdom (GB)

2

Priority Number:

9814709

Priority Date:

08/07/1998

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/12;

Filing date	Document type	Number of pages